Evidence map›Paper›PMID 39220048›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2024

Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging.

Sunwoo Kwak, Hamed Akbari, Jose A Garcia, Suyash Mohan, Yehuda Dicker, Chiharu Sako, Yuji Matsumoto, MacLean P Nasrallah, Mahmoud Shalaby, Donald M O'Rourke and 16 more

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sunwoo KwakUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.
Hamed AkbariSanta Clara University, School of Engineering, Department of Bioengineering, Santa Clara, California, United States.ORCID https://orcid.org/0000-0001-9786-3707
Jose A GarciaUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.
Suyash MohanUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0002-4025-115X
Yehuda DickerColumbia University, School of Engineering, Department of Computer Science, New York, United States.
Chiharu SakoUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0003-3243-3954
Yuji MatsumotoUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.
MacLean P NasrallahUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.
Mahmoud ShalabyMercy Catholic Medical Center, Department of Radiology, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0002-8916-7047
Donald M O'RourkeUniversity of Pennsylvania, Perelman School of Medicine, Department of Neurosurgery, Philadelphia, Pennsylvania, United States.
Russel T ShinoharaUniversity of Pennsylvania, Perelman School of Medicine, Center for Biomedical Image Computing and Analytics, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0001-8627-8203
Fang LiuUniversity of Pennsylvania, Perelman School of Medicine, Department of Biostatistics and Epidemiology, Philadelphia, Pennsylvania, United States.
Chaitra BadveCase Western Reserve University, University Hospitals Cleveland Medical Center, Department of Radiology, Cleveland, Ohio, United States.ORCID https://orcid.org/0000-0001-8547-8019
Jill S Barnholtz-SloanNational Cancer Institute, Center for Biomedical Informatics and Information Technology, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland, United States.
Andrew E SloanPiedmont Healthcare, Division of Neuroscience, Atlanta, Georgia, United States.
Matthew LeeNYU Grossman School of Medicine, Department of Radiology, New York, United States.ORCID https://orcid.org/0000-0001-8816-1076
Rajan JainNYU Grossman School of Medicine, Department of Radiology, New York, United States.
Santiago CepedaUniversity Hospital Río Hortega, Valladolid, Spain.ORCID https://orcid.org/0000-0003-1667-8548
Arnab ChakravartiOhio State University Wexner Medical Center, Department of Radiation Oncology, Columbus, Ohio, United States.
Joshua D PalmerOhio State University Wexner Medical Center, Department of Radiation Oncology, Columbus, Ohio, United States.ORCID https://orcid.org/0000-0003-3311-0129
Adam P DickerThomas Jefferson University, Sidney Kimmel Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania, United States.
Gaurav ShuklaThomas Jefferson University, Sidney Kimmel Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania, United States.ORCID https://orcid.org/0000-0001-7605-9365
Adam E FlandersThomas Jefferson University, Sidney Kimmel Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania, United States.
Wenyin ShiThomas Jefferson University, Sidney Kimmel Cancer Center, Department of Radiation Oncology, Philadelphia, Pennsylvania, United States.
Graeme F WoodworthUniversity of Maryland, School of Medicine, Department of Neurosurgery, Baltimore, Maryland, United States.
Christos DavatzikosUniversity of Pennsylvania, Perelman School of Medicine, Department of Radiology, Philadelphia, Pennsylvania, United States.

Funding

Statistical atlases of brain tumor MRI:do imaging phenotypes predict progression?R01NS042645 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DAVATZIKOS, CHRISTOS · 2002 to 2024
$8.7M
Generalizable quantitative imaging and machine learning signatures in glioblastoma, for precision diagnostics and personalized treatment: the ReSPOND consortiumR01CA269948 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Christos Davatzikos · 2022 to 2026
$3.2M
NCI NIH HHS R01 CA269948
6 · The paper itself

Abstract

Purpose: Glioblastoma (GBM) is the most common and aggressive primary adult brain tumor. The standard treatment approach is surgical resection to target the enhancing tumor mass, followed by adjuvant chemoradiotherapy. However, malignant cells often extend beyond the enhancing tumor boundaries and infiltrate the peritumoral edema. Traditional supervised machine learning techniques hold potential in predicting tumor infiltration extent but are hindered by the extensive resources needed to generate expertly delineated regions of interest (ROIs) for training models on tissue most and least likely to be infiltrated. Approach: We developed a method combining expert knowledge and training-based data augmentation to automatically generate numerous training examples, enhancing the accuracy of our model for predicting tumor infiltration through predictive maps. Such maps can be used for targeted supra-total surgical resection and other therapies that might benefit from intensive yet well-targeted treatment of infiltrated tissue. We apply our method to preoperative multi-parametric magnetic resonance imaging (mpMRI) scans from a subset of 229 patients of a multi-institutional consortium (Radiomics Signatures for Precision Diagnostics) and test the model on subsequent scans with pathology-proven recurrence. Results: Leave-one-site-out cross-validation was used to train and evaluate the tumor infiltration prediction model using initial pre-surgical scans, comparing the generated prediction maps with follow-up mpMRI scans confirming recurrence through post-resection tissue analysis. Performance was measured by voxel-wised odds ratios (ORs) across six institutions: University of Pennsylvania (OR: 9.97), Ohio State University (OR: 14.03), Case Western Reserve University (OR: 8.13), New York University (OR: 16.43), Thomas Jefferson University (OR: 8.22), and Rio Hortega (OR: 19.48). Conclusions: The proposed model demonstrates that mpMRI analysis using deep learning can predict infiltration in the peri-tumoral brain region for GBM patients without needing to train a model using expert ROI drawings. Results for each institution demonstrate the model's generalizability and reproducibility.

Indexed as

deep learningglioblastomainfiltrationmulti-parametric MRIrecurrence

Identifiers

PMID39220048
PMCPMC11363410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.